Lotus Pharmaceutical Co Ltd
Lotus Pharmaceutical's Climate Target Data Preview
As of 2024, Lotus Pharmaceutical has disclosed 2 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 2 absolute reduction targets, signaling the company’s commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Lotus Pharmaceutical ’s climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Absolute-based Target* | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  a | 2025 |
Absolute-based Target* | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) | Copy restricted. Please purchase to unlock this data.  a | 2030 |
Verified Sources Behind Lotus Pharmaceutical’s Climate Targets Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Lotus Pharmaceutical’s data sources below and access millions more through our Disclosure Search.
Insights into Lotus Pharmaceutical's Greenhouse Gas Emissions Pathways
As of 2024, Lotus Pharmaceutical has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions. a
Does Lotus Pharmaceutical have a target to reduce the emissions from its operations?
As of 2024, Lotus Pharmaceutical has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources. a
Lotus Pharmaceutical's most ambitious operational target is to reduce these emissions by 36% by 2030, compared to a baseline of 21,309 Metric Tonnes of CO2 equivalent (mtCO2e) in 2022. a
As of 2024, Lotus Pharmaceutical is ahead of schedule on its operational emissions reduction target, having achieved 75.97% of the planned reduction. a